WATSON PHARMACEUTICALS (NY:WPI)
36.96
0.85 (2.25%)
| WATSON PHARMACEUTICALS (NY:WPI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $37.81 | 52 Week High | $38.48 | ||
| Open | $37.28 | 52 Week Low | $22.16 | ||
| Day High | $37.33 | P/E | 19.15 | ||
| Day Low | $36.83 | EPS | $1.93 | ||
| Volume | 474,901 | ||||
| More WPI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| MYL | 6 | MRX | 5 |
| TEVA | 5 | KG | 4 |
| ACL | 3 | CMCSA | 3 |
| AGN | 3 | FRX | 3 |
| SEPR | 3 | WCRX | 3 |
| OII | 2 | WFMI | 2 |
Entities who have mentioned WPI
- Citi | View Related Stories »
- Wachovia | View Related Stories »
- Crude Oil | View Related Stories »
- David Moenning | View Related Stories »
- JPMorgan | View Related Stories »
- Credit Suisse | View Related Stories »
- UBS | View Related Stories »
- Goldman Sachs Conviction Sell List | View Related Stories »
- Goldman Sachs | View Related Stories »
- Morgan Stanley | View Related Stories »
- Banc of America | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Federal Open Market Committee | View Related Stories »
- Twitter | View Related Stories »
- Needham & Co | View Related Stories »
- Robert W Baird | View Related Stories »
- Argus | View Related Stories »
- Matrix USA | View Related Stories »
- Alan Greenspan | View Related Stories »
- Scopia Capital | View Related Stories »
- Barclays | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- HSBC | View Related Stories »
- Bear Stearns | View Related Stories »
View All Major News StreetInsider.com Major News for WPI
- Watson Pharma (WPI) Posts Q3 adj.-EPS of $0.66, Beats by 1c;
- Watson Pharma (WPI) Reports Q2 Adj-EPS of $0.61, Beats by 4c; Raises FY09 Outlook
- Watson Pharmaceuticals (WPI) Acquires Privatly Held Arrow Group for $1.75 Billion
View All ReportsStreetInsider.com Reports on WPI
- Watson Pharma (WPI) Posts Q3 adj.-EPS of $0.66, Beats by 1c;
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Watson Pharma (WPI) Sibsidiary Watson Labs Settles with Barr Labs Over Oxytrol Patent Litigation
- Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI
- Watson Pharmaceuticals (WPI) Receives FDA Approval for Generic PLAN B for Over-the-Counter Use
View All Press ReleasesCompany Press Releases on WPI
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- Watson Names Robert A. Stewart Senior Vice President, Global Operations
- Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference
- Watson to Present at Credit Suisse Healthcare Conference
- Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
StreetInsider Reports on WPI by Category
View All BlogsBlogs on WPI
- Watson Pharmaceutical Financial Gauge Analysis for the September 2009 Quarter
- 20 Large Cap Opportunities
- Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter
- The Best and Worst International ETFs in 2009
- Cephalon's Upside and Downside
View All FilingsSEC Filings on WPI
- Form 4 WATSON PHARMACEUTICALS For: Nov 16 Filed by: Stewart Robert A
- Form 10-Q WATSON PHARMACEUTICALS For: Sep 30
- Form 8-K WATSON PHARMACEUTICALS For: Nov 04
- Form 4 JOYCE R TODD For: Oct 30
- Form 8-K WATSON PHARMACEUTICALS For: Oct 30
Comments on WPI
No comments are currently available.
